Exagen Inc. has announced conditional approval from the New York State Department of Health for its innovative new biomarker ...
A new study investigates the role of Krüppel-like factor 2 (KLF2, a protein coding gene involved in a variety of regulatory ...
Lupus affects different people in different ways, and skin problems like rashes or sores re common. In a new study, people ...
In the Phase 2b CARE study, the investigational drug, cenerimod, demonstrated safe and effective results for treatment of adults with moderate-to-severe systemic lupus erythematosus (SLE). The drug’s ...
In a new study published in Lupus Science & Medicine, researchers reviewed randomized clinical trials (RCTs) to assess therapies for initial management of lupus nephritis (LN), focusing on their ...
We understand the incredible stress, uncertainty and emotional distress that a natural disaster causes those affected by it. As wildfires continue to impact the Southern California region, we wanted ...
The REGINA SLE clinical trial is testing an investigational study drug to see if it may safely and effectively reduce symptoms of moderate to severe systemic lupus erythematosus in adults.
The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy. The Lupus Foundation of America ...
The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy. The Lupus Foundation of America ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback